During the past decade, Fundacao Zerbini Casa Da Aids conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fundacao Zerbini Casa Da Aids" are "HIV Infections" (3 trials). Many other conditions were trialed in "Fundacao Zerbini Casa Da Aids" in a lesser frequency.

Most popular intervention types in "Fundacao Zerbini Casa Da Aids" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Lamivudine" (2 trials), "Lopinavir/Ritonavir" (2 trials), "Stavudine" (2 trials), "Efavirenz" (1 trials) and "Nelfinavir mesylate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacao Zerbini Casa Da Aids" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fundacao Zerbini Casa Da Aids". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Fundacao Zerbini Casa Da Aids, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundacao Zerbini Casa Da Aids, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".